Sugi Predict

Sugi Predict / Targets / GTF3C4

GTF3C4

General transcription factor 3C polypeptide 4 · Q9UKN8 · GTF3C4 on Sugi Atlas →

0 patent compounds predicted against GTF3C4, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to GTF3C4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Symbicort ® on GR in Sputum in COPD PHASE4COMPLETED
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room PHASE2/PHASE3COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection nanUNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Diet, Genetics, and CVD Risk Factor Response in Blacks nanCOMPLETED
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Genetic Studies of Inflammatory Bowel Disease nanCOMPLETED
A Study of the Genetic Analysis of Brain Disorders nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism nanUNKNOWN
Family Resilience Initiative Research Program nanUNKNOWN
The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations nanCOMPLETED
Nasturtium (Tropaeolum Majus L) Intake and Biochemical Parameters in Pre-diabetic Subjects in Bogota Colombia nanCOMPLETED
Genomic Translation for Amyotrophic Lateral Sclerosis Care nanCOMPLETED
Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV. nanUNKNOWN
Recombinant Interferon Alfa-2b in Treating Patients With Melanoma nanCOMPLETED
Child Development and Genetic Biomarkers(II): Gene Verification and Data Integration nanUNKNOWN
Risk Factors for the Development of Celiac Disease in Genetically Predisposed Children nanUNKNOWN
Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone. nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Pheno- & Genotyping POF (WHO III) nanUNKNOWN
Caffeine, Genetic Variation and Athletic Performance nanUNKNOWN
Role of Nitric Oxide in Diabetic Patients With Erectile Dysfunction nanCOMPLETED
Characterizing the Role of Pain Sensitivity in Acute to Persistent Low Back Pain nanCOMPLETED
Study on the Biological Prediction Models of Radiation Pneumonitis nanUNKNOWN
Genetic Determinants and Clinical Consequences of Early-onset Severe Obesity nanUNKNOWN
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a GTF3C4 binder may also engage these)

ProteinNameSimilarity
Q8BMQ2 — 1.000 Q8BMQ2 →
Q4V9P9 — 0.996 Q4V9P9 →
Q8BJW5 — 0.996 Q8BJW5 →
Q6DDJ5 — 0.993 Q6DDJ5 →
Q3MHH2 — 0.993 Q3MHH2 →
GSAP Gamma-secretase-activating protein 0.993 landscape →
Q9Z2U2 — 0.993 Q9Z2U2 →
Q6INI5 — 0.993 Q6INI5 →
Q8WUM0 — 0.993 Q8WUM0 →
Q4VSN4 — 0.992 Q4VSN4 →
Q6GM71 — 0.992 Q6GM71 →
A8WHR0 — 0.992 A8WHR0 →
F4IGA5 — 0.992 F4IGA5 →
NUP160 Nuclear pore complex protein Nup160 0.992 landscape →
E9Q555 — 0.992 E9Q555 →
Q6NV72 — 0.992 Q6NV72 →
O65418 — 0.992 O65418 →
Q6DRL4 — 0.991 Q6DRL4 →
Q6XUX1 — 0.991 Q6XUX1 →
Q13129 — 0.991 Q13129 →
F4K4J0 — 0.991 F4K4J0 →
Q9Z0W3 — 0.991 Q9Z0W3 →
B5E0H4 — 0.991 B5E0H4 →
F6S215 — 0.991 F6S215 →
Q6TNU3 — 0.991 Q6TNU3 →
Q91VB4 — 0.991 Q91VB4 →
P97313 — 0.990 P97313 →
E9Q7R9 — 0.990 E9Q7R9 →
Q9VPH0 — 0.990 Q9VPH0 →
Q6NU22 — 0.990 Q6NU22 →